Literature DB >> 31092554

The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for GRIA2 mRNA processing.

Maeve Tischbein1, Desiree M Baron1, Yen-Chen Lin1, Katherine V Gall1, John E Landers1, Claudia Fallini1, Daryl A Bosco2.   

Abstract

Excitotoxic levels of glutamate represent a physiological stress that is strongly linked to amyotrophic lateral sclerosis (ALS) and other neurological disorders. Emerging evidence indicates a role for neurodegenerative disease-linked RNA-binding proteins (RBPs) in the cellular stress response. However, the relationships between excitotoxicity, RBP function, and disease have not been explored. Here, using primary cortical and motor neurons, we found that excitotoxicity induced the translocation of select ALS-linked RBPs from the nucleus to the cytoplasm within neurons. RBPs affected by excitotoxicity included TAR DNA-binding protein 43 (TDP-43) and, most robustly, fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS). We noted that FUS is translocated through a calcium-dependent mechanism and that its translocation coincides with striking alterations in nucleocytoplasmic transport. Furthermore, glutamate-induced up-regulation of glutamate ionotropic receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type subunit 2 (GRIA2) in neurons depended on FUS expression, consistent with a functional role for FUS in excitotoxic stress. These findings reveal molecular links among prominent factors in neurodegenerative diseases, namely excitotoxicity, disease-associated RBPs, and nucleocytoplasmic transport.
© 2019 Tischbein et al.

Entities:  

Keywords:  RNA transport; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); excitatory neurotransmission; excitotoxicity; fused in sarcoma/translocated in liposarcoma (FUS/TLS); glutamate; glutamate ionotropic receptor AMPA type subunit 2 (Gria2); glutamate receptor 2 (GluA2); neurodegeneration; nucleocytoplasmic transport

Mesh:

Substances:

Year:  2019        PMID: 31092554      PMCID: PMC6664169          DOI: 10.1074/jbc.RA118.005933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Optimized large-scale production of high titer lentivirus vector pseudotypes.

Authors:  Miguel Sena-Esteves; Jessica C Tebbets; Sabine Steffens; Timothy Crombleholme; Alan W Flake
Journal:  J Virol Methods       Date:  2004-12-15       Impact factor: 2.014

2.  Excitotoxic death of a subset of embryonic rat motor neurons in vitro.

Authors:  H J Fryer; R J Knox; S M Strittmatter; R G Kalb
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

3.  Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.

Authors:  Jozsef Gal; Jiayu Zhang; David M Kwinter; Jianjun Zhai; Hongge Jia; Jianhang Jia; Haining Zhu
Journal:  Neurobiol Aging       Date:  2010-07-31       Impact factor: 4.673

Review 4.  Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis.

Authors:  Matthew J Fogarty
Journal:  Brain Res Bull       Date:  2018-06-02       Impact factor: 4.077

5.  Alteration of the nuclear pore complex in Ca(2+)-mediated cell death.

Authors:  D Bano; D Dinsdale; A Cabrera-Socorro; S Maida; N Lambacher; B McColl; E Ferrando-May; M O Hengartner; P Nicotera
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

6.  Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity.

Authors:  Philip Van Damme; Elke Bogaert; Maarten Dewil; Nicole Hersmus; Dora Kiraly; Wendy Scheveneels; Ilse Bockx; Dries Braeken; Nathalie Verpoorten; Kristien Verhoeven; Vincent Timmerman; Paul Herijgers; Geert Callewaert; Peter Carmeliet; Ludo Van Den Bosch; Wim Robberecht
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

Review 7.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

8.  Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.

Authors:  Brian A Keller; Kathryn Volkening; Cristian A Droppelmann; Lee Cyn Ang; Rosa Rademakers; Michael J Strong
Journal:  Acta Neuropathol       Date:  2012-09-01       Impact factor: 17.088

Review 9.  Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.

Authors:  Hong Joo Kim; J Paul Taylor
Journal:  Neuron       Date:  2017-10-11       Impact factor: 17.173

Review 10.  The Role of Post-Translational Modifications on Prion-Like Aggregation and Liquid-Phase Separation of FUS.

Authors:  Shannon N Rhoads; Zachary T Monahan; Debra S Yee; Frank P Shewmaker
Journal:  Int J Mol Sci       Date:  2018-03-16       Impact factor: 5.923

View more
  9 in total

Review 1.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

2.  Nuclear RNA transcript levels modulate nucleocytoplasmic distribution of ALS/FTD-associated protein FUS.

Authors:  Yueh-Lin Tsai; Yu Chun Mu; James L Manley
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

3.  Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway.

Authors:  Yen-Chen Lin; Meenakshi Sundaram Kumar; Nandini Ramesh; Eric N Anderson; Aivi T Nguyen; Boram Kim; Simon Cheung; Justin A McDonough; William C Skarnes; Rodrigo Lopez-Gonzalez; John E Landers; Nicolas L Fawzi; Ian R A Mackenzie; Edward B Lee; Jeffrey A Nickerson; David Grunwald; Udai B Pandey; Daryl A Bosco
Journal:  Nat Neurosci       Date:  2021-05-31       Impact factor: 24.884

Review 4.  Nucleo-cytoplasmic transport defects and protein aggregates in neurodegeneration.

Authors:  Giacomo Bitetto; Alessio Di Fonzo
Journal:  Transl Neurodegener       Date:  2020-07-03       Impact factor: 8.014

Review 5.  RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.

Authors:  Takashi Hosaka; Hiroshi Tsuji; Shin Kwak
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

6.  A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.

Authors:  Gaël Nicolas; Myriam Sévigny; François Lecoquierre; Florent Marguet; Andréanne Deschênes; Maria Carment Del Pelaez; Sébastien Feuillette; Anaïs Audebrand; Magalie Lecourtois; Stéphane Rousseau; Anne-Claire Richard; Kévin Cassinari; Vincent Deramecourt; Charles Duyckaerts; Anne Boland; Jean-François Deleuze; Vincent Meyer; Jordi Clarimon Echavarria; Ellen Gelpi; Haruhiko Akiyama; Masato Hasegawa; Ito Kawakami; Tsz H Wong; Jeroen G J Van Rooij; John C Van Swieten; Dominique Campion; Paul A Dutchak; David Wallon; Flavie Lavoie-Cardinal; Annie Laquerrière; Anne Rovelet-Lecrux; Chantelle F Sephton
Journal:  Acta Neuropathol Commun       Date:  2022-02-12       Impact factor: 7.801

Review 7.  Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases.

Authors:  Yu-Qing Ni; Hui Xu; You-Shuo Liu
Journal:  Front Mol Neurosci       Date:  2022-03-14       Impact factor: 5.639

8.  FUS contributes to mTOR-dependent inhibition of translation.

Authors:  Myriam Sévigny; Isabelle Bourdeau Julien; Janani Priya Venkatasubramani; Jeremy B Hui; Paul A Dutchak; Chantelle F Sephton
Journal:  J Biol Chem       Date:  2020-10-20       Impact factor: 5.157

Review 9.  Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Noriko Kubota; Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.